Here, by utilizing bioinformatics, lung cancer cells, and tissue microarray from lung adenocarcinoma, we examined the clinical significance of the MYBL2-RRM2 axis in lung adenocarcinoma. This evidence concerns the gene MYBL2 and lung carcinoma.